Koei Ikeda

Kumamoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

A lung squamous cell carcinoma demonstrating spontaneous partial regression of the primary tumor with lymph node metastasis: a case report with analysis of the tumor immune microenvironment.

A lung squamous cell carcinoma demonstrating spontaneous partial regression of the primary tumor with lymph node metastasis: a case report with analysis of the tumor immune microenvironment.

Journal: Translational lung cancer research

Published: December 20, 2025

Integrative analysis of T cell subset-specific ICOS expression and tumor HLA class I/II expression in lung adenocarcinoma: implications for their interaction and clinical outcome.

Integrative analysis of T cell subset-specific ICOS expression and tumor HLA class I/II expression in lung adenocarcinoma: implications for their interaction and clinical outcome.

Journal: Cancer immunology, immunotherapy : CII

Published: December 03, 2025

Phase 2 feasibility study of adjuvant chemotherapy with cisplatin (CDDP) and TS-1, followed by alternate-day TS-1 maintenance therapy, in patients with completely resected pathological stage II-IIIA non-small cell lung cancer.

Phase 2 feasibility study of adjuvant chemotherapy with cisplatin (CDDP) and TS-1, followed by alternate-day TS-1 maintenance therapy, in patients with completely resected pathological stage II-IIIA non-small cell lung cancer.

Journal: Journal of thoracic disease

Published: July 25, 2025

Adjuvant therapy in pStage IA1-IIA lung adenocarcinoma (pN0): A multicenter study focusing on EGFR mutations and recurrence patterns (CReGYT-01 EGFR study).

Adjuvant therapy in pStage IA1-IIA lung adenocarcinoma (pN0): A multicenter study focusing on EGFR mutations and recurrence patterns (CReGYT-01 EGFR study).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 30, 2025

The expression of PD-1 ligands in the immune microenvironment was altered in TTF-1-negative lung adenocarcinoma.

The expression of PD-1 ligands in the immune microenvironment was altered in TTF-1-negative lung adenocarcinoma.

Journal: Human cell

Published: March 26, 2025

Hippo pathway controls biopterin metabolism to shield adjacent cells from ferroptosis in lung cancer.

Hippo pathway controls biopterin metabolism to shield adjacent cells from ferroptosis in lung cancer.

Journal: EMBO reports

Published: August 22, 2024

Comparison of survivals between sublobar resection and lobar resection for patients with clinical stage I non-small cell lung cancer and interstitial lung disease: a propensity score matching analysis.

Comparison of survivals between sublobar resection and lobar resection for patients with clinical stage I non-small cell lung cancer and interstitial lung disease: a propensity score matching analysis.

Journal: Thoracic cancer

Published: May 02, 2024

NUF2 Expression in Cancer Tissues and Lymph Nodes Suggests Post-Surgery Recurrence of Non-Small Cell Lung Cancer.

NUF2 Expression in Cancer Tissues and Lymph Nodes Suggests Post-Surgery Recurrence of Non-Small Cell Lung Cancer.

Journal: Diagnostics (Basel, Switzerland)

Published: January 12, 2024

A Case of Aggressive Lung Squamous Cell Carcinoma With Aberrant Cytoplasmic p53 Aggregation.

A Case of Aggressive Lung Squamous Cell Carcinoma With Aberrant Cytoplasmic p53 Aggregation.

Journal: Cancer diagnosis & prognosis

Published: January 03, 2024

Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an EGFR mutation.

Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an EGFR mutation.

Journal: Journal of thoracic disease

Published: November 08, 2023

IL-32 production from lung adenocarcinoma cells is potentially involved in immunosuppressive microenvironment.

IL-32 production from lung adenocarcinoma cells is potentially involved in immunosuppressive microenvironment.

Journal: Medical molecular morphology

Published: October 23, 2023

PD-L2 overexpression on tumor-associated macrophages is one of the predictors for better prognosis in lung adenocarcinoma.

PD-L2 overexpression on tumor-associated macrophages is one of the predictors for better prognosis in lung adenocarcinoma.

Journal: Medical molecular morphology

Published: May 18, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026